CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- 4 Open-market sale 10% owner sold 10,000 shares at $2.97 ($29,700)
- 4 Grant or award President and CEO acquired 6,242 shares (grant or award)
- 4 Grant or award President and CEO acquired 5,171 shares (grant or award)
- 4 Open-market buy Director bought 5,000 shares at $2.57 ($12,848)
- 4 Open-market buy Director bought 10,000 shares at $2.55 ($25,500)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 6,000 shares at $1.64 ($9,844)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 65,513 shares (option exercise)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Exercise or conversion Director acquired 8,000 shares (option exercise)
- 4 Open-market sale 10% owner sold 10,000 shares at $2.97 ($29,700)
- 4 Grant or award Director acquired 12,238 shares (grant or award)
- 4 Grant or award Director acquired 20,455 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 15 of 39 · 776 filings